Systematic review with meta-analysis: liver manifestations and outcomes in COVID-19.

Anand V KulkarniPramod KumarHarsh Vardhan TevethiaMadhumita PremkumarJuan Pablo ArabRoberto CandiaRupjyoti TalukdarMithun SharmaXiaolong QiPadaki Nagaraja RaoDuvvuru Nageshwar Reddy

Published in: Alimentary pharmacology & therapeutics (2020)

Elevated liver chemistries are common at presentation and during COVID-19. The severity of elevated liver chemistries correlates with the outcome of COVID-19. The presence of CLD does not alter the outcome of COVID-19. Further studies are needed to analyse the outcomes of compensated and decompensated liver disease.

Keyphrases

coronavirus disease
sars cov
heart failure
respiratory syndrome coronavirus
type diabetes